IF=10.8997,Journal for Immunotherapy of Cancer,天境生物制藥,表達(dá)細(xì)胞系.
792?Givastomig, a novel Claudin18.2/4–1BB bispecific antibody, exerts bystander tumor-killing and synergistic anti-tumor activity with therapeutics in 1L/2L treatment for gastric cancer